Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease.

Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J.

J Alzheimers Dis. 2014;38(1):111-20. doi: 10.3233/JAD-130722.

2.

Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.

Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF.

Neurology. 2007 May 22;68(21):1809-14.

3.

Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach.

Pan S, Wang Y, Quinn JF, Peskind ER, Waichunas D, Wimberger JT, Jin J, Li JG, Zhu D, Pan C, Zhang J.

J Proteome Res. 2006 Oct;5(10):2769-79.

PMID:
17022648
4.

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

Abdi F, Quinn JF, Jankovic J, McIntosh M, Leverenz JB, Peskind E, Nixon R, Nutt J, Chung K, Zabetian C, Samii A, Lin M, Hattan S, Pan C, Wang Y, Jin J, Zhu D, Li GJ, Liu Y, Waichunas D, Montine TJ, Zhang J.

J Alzheimers Dis. 2006 Aug;9(3):293-348.

PMID:
16914840

Supplemental Content

Loading ...
Support Center